▶ 調査レポート

世界の強迫性障害治療薬市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Obsessive-Compulsive Disorder Drugs Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の強迫性障害治療薬市場規模・現状・予測(2021年-2027年) / Global Obsessive-Compulsive Disorder Drugs Market Size, Status and Forecast 2021-2027 / QFJ1-5903資料のイメージです。• レポートコード:QFJ1-5903
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、97ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、強迫性障害治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(SSRI、TCA、その他)、用途別市場規模(病院、クリニック、研究所、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・強迫性障害治療薬の市場動向
・企業の競争状況、市場シェア
・強迫性障害治療薬の種類別市場規模と予測2016-2027(SSRI、TCA、その他)
・強迫性障害治療薬の用途別市場規模と予測2016-2027(病院、クリニック、研究所、その他)
・強迫性障害治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・強迫性障害治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・強迫性障害治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・強迫性障害治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・強迫性障害治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Eli Lilly and Co.、GlaxoSmithKline Plc、H. Lundbeck AS、Novartis AG、Pfizer Inc.)
・結論

Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called “compulsions”), or has certain thoughts repeatedly (called “obsessions”).
The launch of new molecules is one of the primary drivers for the obsessive-compulsive disorder drugs market growth. Conventional therapies used to treat the condition are only short-term treatment. The conventional anti-anxiety, antipsychotic, and antidepressant drugs are administered along with behavioral therapies and psychotherapy. The current long-term treatment involves the management of the condition, which requires patient compliance that has its drawbacks. Vendors are leveraging this situation and are focusing on the R&D of new drugs with improved bioavailability, pharmacology, safety, and dosage parameters. These new OCD drugs are currently being evaluated and will enroll soon by a series of new launches. As a result, the demand for these drugs will increase.

Market Analysis and Insights: Global Obsessive-Compulsive Disorder Drugs Market
The global Obsessive-Compulsive Disorder Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Obsessive-Compulsive Disorder Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Obsessive-Compulsive Disorder Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Obsessive-Compulsive Disorder Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Obsessive-Compulsive Disorder Drugs market.

Global Obsessive-Compulsive Disorder Drugs Scope and Market Size
Obsessive-Compulsive Disorder Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Obsessive-Compulsive Disorder Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
SSRI
TCA
Others

Segment by Application
Hospital
Clinic
Research Institute
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly and Co.
GlaxoSmithKline Plc
H. Lundbeck AS
Novartis AG
Pfizer Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Obsessive-Compulsive Disorder Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 SSRI
1.2.3 TCA
1.2.4 Others
1.3 Market by Application
1.3.1 Global Obsessive-Compulsive Disorder Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Obsessive-Compulsive Disorder Drugs Market Perspective (2016-2027)
2.2 Obsessive-Compulsive Disorder Drugs Growth Trends by Regions
2.2.1 Obsessive-Compulsive Disorder Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Obsessive-Compulsive Disorder Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Obsessive-Compulsive Disorder Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Obsessive-Compulsive Disorder Drugs Industry Dynamic
2.3.1 Obsessive-Compulsive Disorder Drugs Market Trends
2.3.2 Obsessive-Compulsive Disorder Drugs Market Drivers
2.3.3 Obsessive-Compulsive Disorder Drugs Market Challenges
2.3.4 Obsessive-Compulsive Disorder Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Obsessive-Compulsive Disorder Drugs Players by Revenue
3.1.1 Global Top Obsessive-Compulsive Disorder Drugs Players by Revenue (2016-2021)
3.1.2 Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Obsessive-Compulsive Disorder Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Obsessive-Compulsive Disorder Drugs Revenue
3.4 Global Obsessive-Compulsive Disorder Drugs Market Concentration Ratio
3.4.1 Global Obsessive-Compulsive Disorder Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Obsessive-Compulsive Disorder Drugs Revenue in 2020
3.5 Obsessive-Compulsive Disorder Drugs Key Players Head office and Area Served
3.6 Key Players Obsessive-Compulsive Disorder Drugs Product Solution and Service
3.7 Date of Enter into Obsessive-Compulsive Disorder Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Obsessive-Compulsive Disorder Drugs Breakdown Data by Type
4.1 Global Obsessive-Compulsive Disorder Drugs Historic Market Size by Type (2016-2021)
4.2 Global Obsessive-Compulsive Disorder Drugs Forecasted Market Size by Type (2022-2027)

5 Obsessive-Compulsive Disorder Drugs Breakdown Data by Application
5.1 Global Obsessive-Compulsive Disorder Drugs Historic Market Size by Application (2016-2021)
5.2 Global Obsessive-Compulsive Disorder Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Obsessive-Compulsive Disorder Drugs Market Size (2016-2027)
6.2 North America Obsessive-Compulsive Disorder Drugs Market Size by Type
6.2.1 North America Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2021)
6.2.2 North America Obsessive-Compulsive Disorder Drugs Market Size by Type (2022-2027)
6.2.3 North America Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2027)
6.3 North America Obsessive-Compulsive Disorder Drugs Market Size by Application
6.3.1 North America Obsessive-Compulsive Disorder Drugs Market Size by Application (2016-2021)
6.3.2 North America Obsessive-Compulsive Disorder Drugs Market Size by Application (2022-2027)
6.3.3 North America Obsessive-Compulsive Disorder Drugs Market Size by Application (2016-2027)
6.4 North America Obsessive-Compulsive Disorder Drugs Market Size by Country
6.4.1 North America Obsessive-Compulsive Disorder Drugs Market Size by Country (2016-2021)
6.4.2 North America Obsessive-Compulsive Disorder Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Obsessive-Compulsive Disorder Drugs Market Size (2016-2027)
7.2 Europe Obsessive-Compulsive Disorder Drugs Market Size by Type
7.2.1 Europe Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2021)
7.2.2 Europe Obsessive-Compulsive Disorder Drugs Market Size by Type (2022-2027)
7.2.3 Europe Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2027)
7.3 Europe Obsessive-Compulsive Disorder Drugs Market Size by Application
7.3.1 Europe Obsessive-Compulsive Disorder Drugs Market Size by Application (2016-2021)
7.3.2 Europe Obsessive-Compulsive Disorder Drugs Market Size by Application (2022-2027)
7.3.3 Europe Obsessive-Compulsive Disorder Drugs Market Size by Application (2016-2027)
7.4 Europe Obsessive-Compulsive Disorder Drugs Market Size by Country
7.4.1 Europe Obsessive-Compulsive Disorder Drugs Market Size by Country (2016-2021)
7.4.2 Europe Obsessive-Compulsive Disorder Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size (2016-2027)
8.2 Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Type
8.2.1 Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Application
8.3.1 Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Region
8.4.1 Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Obsessive-Compulsive Disorder Drugs Market Size (2016-2027)
9.2 Latin America Obsessive-Compulsive Disorder Drugs Market Size by Type
9.2.1 Latin America Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Obsessive-Compulsive Disorder Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2027)
9.3 Latin America Obsessive-Compulsive Disorder Drugs Market Size by Application
9.3.1 Latin America Obsessive-Compulsive Disorder Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Obsessive-Compulsive Disorder Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Obsessive-Compulsive Disorder Drugs Market Size by Application (2016-2027)
9.4 Latin America Obsessive-Compulsive Disorder Drugs Market Size by Country
9.4.1 Latin America Obsessive-Compulsive Disorder Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Obsessive-Compulsive Disorder Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size (2016-2027)
10.2 Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Type
10.2.1 Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Application
10.3.1 Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Country
10.4.1 Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly and Co.
11.1.1 Eli Lilly and Co. Company Details
11.1.2 Eli Lilly and Co. Business Overview
11.1.3 Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Introduction
11.1.4 Eli Lilly and Co. Revenue in Obsessive-Compulsive Disorder Drugs Business (2016-2021)
11.1.5 Eli Lilly and Co. Recent Development
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Company Details
11.2.2 GlaxoSmithKline Plc Business Overview
11.2.3 GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Introduction
11.2.4 GlaxoSmithKline Plc Revenue in Obsessive-Compulsive Disorder Drugs Business (2016-2021)
11.2.5 GlaxoSmithKline Plc Recent Development
11.3 H. Lundbeck AS
11.3.1 H. Lundbeck AS Company Details
11.3.2 H. Lundbeck AS Business Overview
11.3.3 H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Introduction
11.3.4 H. Lundbeck AS Revenue in Obsessive-Compulsive Disorder Drugs Business (2016-2021)
11.3.5 H. Lundbeck AS Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Obsessive-Compulsive Disorder Drugs Introduction
11.4.4 Novartis AG Revenue in Obsessive-Compulsive Disorder Drugs Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Obsessive-Compulsive Disorder Drugs Introduction
11.5.4 Pfizer Inc. Revenue in Obsessive-Compulsive Disorder Drugs Business (2016-2021)
11.5.5 Pfizer Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Obsessive-Compulsive Disorder Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of SSRI
Table 3. Key Players of TCA
Table 4. Key Players of Others
Table 5. Global Obsessive-Compulsive Disorder Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Obsessive-Compulsive Disorder Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Obsessive-Compulsive Disorder Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Obsessive-Compulsive Disorder Drugs Market Share by Regions (2016-2021)
Table 9. Global Obsessive-Compulsive Disorder Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Obsessive-Compulsive Disorder Drugs Market Share by Regions (2022-2027)
Table 11. Obsessive-Compulsive Disorder Drugs Market Trends
Table 12. Obsessive-Compulsive Disorder Drugs Market Drivers
Table 13. Obsessive-Compulsive Disorder Drugs Market Challenges
Table 14. Obsessive-Compulsive Disorder Drugs Market Restraints
Table 15. Global Obsessive-Compulsive Disorder Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Obsessive-Compulsive Disorder Drugs Market Share by Players (2016-2021)
Table 17. Global Top Obsessive-Compulsive Disorder Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Obsessive-Compulsive Disorder Drugs as of 2020)
Table 18. Ranking of Global Top Obsessive-Compulsive Disorder Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Obsessive-Compulsive Disorder Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Obsessive-Compulsive Disorder Drugs Product Solution and Service
Table 22. Date of Enter into Obsessive-Compulsive Disorder Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Obsessive-Compulsive Disorder Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Obsessive-Compulsive Disorder Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Obsessive-Compulsive Disorder Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Obsessive-Compulsive Disorder Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Obsessive-Compulsive Disorder Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Obsessive-Compulsive Disorder Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Obsessive-Compulsive Disorder Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Obsessive-Compulsive Disorder Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Obsessive-Compulsive Disorder Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Obsessive-Compulsive Disorder Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Obsessive-Compulsive Disorder Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Obsessive-Compulsive Disorder Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Obsessive-Compulsive Disorder Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Obsessive-Compulsive Disorder Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Obsessive-Compulsive Disorder Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Obsessive-Compulsive Disorder Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Obsessive-Compulsive Disorder Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Obsessive-Compulsive Disorder Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Eli Lilly and Co. Company Details
Table 63. Eli Lilly and Co. Business Overview
Table 64. Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Product
Table 65. Eli Lilly and Co. Revenue in Obsessive-Compulsive Disorder Drugs Business (2016-2021) & (US$ Million)
Table 66. Eli Lilly and Co. Recent Development
Table 67. GlaxoSmithKline Plc Company Details
Table 68. GlaxoSmithKline Plc Business Overview
Table 69. GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Product
Table 70. GlaxoSmithKline Plc Revenue in Obsessive-Compulsive Disorder Drugs Business (2016-2021) & (US$ Million)
Table 71. GlaxoSmithKline Plc Recent Development
Table 72. H. Lundbeck AS Company Details
Table 73. H. Lundbeck AS Business Overview
Table 74. H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Product
Table 75. H. Lundbeck AS Revenue in Obsessive-Compulsive Disorder Drugs Business (2016-2021) & (US$ Million)
Table 76. H. Lundbeck AS Recent Development
Table 77. Novartis AG Company Details
Table 78. Novartis AG Business Overview
Table 79. Novartis AG Obsessive-Compulsive Disorder Drugs Product
Table 80. Novartis AG Revenue in Obsessive-Compulsive Disorder Drugs Business (2016-2021) & (US$ Million)
Table 81. Novartis AG Recent Development
Table 82. Pfizer Inc. Company Details
Table 83. Pfizer Inc. Business Overview
Table 84. Pfizer Inc. Obsessive-Compulsive Disorder Drugs Product
Table 85. Pfizer Inc. Revenue in Obsessive-Compulsive Disorder Drugs Business (2016-2021) & (US$ Million)
Table 86. Pfizer Inc. Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Obsessive-Compulsive Disorder Drugs Market Share by Type: 2020 VS 2027
Figure 2. SSRI Features
Figure 3. TCA Features
Figure 4. Others Features
Figure 5. Global Obsessive-Compulsive Disorder Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Research Institute Case Studies
Figure 9. Other Case Studies
Figure 10. Obsessive-Compulsive Disorder Drugs Report Years Considered
Figure 11. Global Obsessive-Compulsive Disorder Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Obsessive-Compulsive Disorder Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Obsessive-Compulsive Disorder Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Obsessive-Compulsive Disorder Drugs Market Share by Regions (2022-2027)
Figure 15. Global Obsessive-Compulsive Disorder Drugs Market Share by Players in 2020
Figure 16. Global Top Obsessive-Compulsive Disorder Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Obsessive-Compulsive Disorder Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Obsessive-Compulsive Disorder Drugs Revenue in 2020
Figure 18. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Obsessive-Compulsive Disorder Drugs Market Share by Type (2016-2027)
Figure 22. North America Obsessive-Compulsive Disorder Drugs Market Share by Application (2016-2027)
Figure 23. North America Obsessive-Compulsive Disorder Drugs Market Share by Country (2016-2027)
Figure 24. United States Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Obsessive-Compulsive Disorder Drugs Market Share by Type (2016-2027)
Figure 28. Europe Obsessive-Compulsive Disorder Drugs Market Share by Application (2016-2027)
Figure 29. Europe Obsessive-Compulsive Disorder Drugs Market Share by Country (2016-2027)
Figure 30. Germany Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Obsessive-Compulsive Disorder Drugs Market Share by Region (2016-2027)
Figure 40. China Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Obsessive-Compulsive Disorder Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Obsessive-Compulsive Disorder Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Obsessive-Compulsive Disorder Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Obsessive-Compulsive Disorder Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Obsessive-Compulsive Disorder Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Eli Lilly and Co. Revenue Growth Rate in Obsessive-Compulsive Disorder Drugs Business (2016-2021)
Figure 60. GlaxoSmithKline Plc Revenue Growth Rate in Obsessive-Compulsive Disorder Drugs Business (2016-2021)
Figure 61. H. Lundbeck AS Revenue Growth Rate in Obsessive-Compulsive Disorder Drugs Business (2016-2021)
Figure 62. Novartis AG Revenue Growth Rate in Obsessive-Compulsive Disorder Drugs Business (2016-2021)
Figure 63. Pfizer Inc. Revenue Growth Rate in Obsessive-Compulsive Disorder Drugs Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed